In addition, poor SARS-CoV-2 outcomes in patients with gout have been associated with increased serum levels of tumor necrosis factor a (TNF-a), interleukin-6 (IL-6) and interleukin-8 (IL-8) [5]. This evidence concerns the gene IL6 and gout.